Lack of effects of acemetacin on signalling pathways
for leukocyte adherence may explain its
gastrointestinal safety

dc.contributor.author	Ortiz Ramírez, Mario Isidoro	en_US
dc.date.accessioned	2013-11-05T22:00:09Z
dc.date.available	2013-11-05T22:00:09Z
dc.date.issued	2008	en_US
dc.identifier.citation	Chávez-Piña AE, Vong L, McKnight W, Dicay M, Zanardo RC, Ortiz MI, Castañeda-Hernández G, Wallace JL. Lack of effects of acemetacin on signalling pathways for leukocyte adherence may explain its gastrointestinal safety. Br J Pharmacol. 2008;155(6):857-64. ISSN:1476-5381.	es
dc.identifier.uri	https://repository.uaeh.edu.mx/bitstream/handle/123456789/11893
dc.description.abstract	Acemetacin is a non-steroidal anti-inflammatory drug which is rapidly bioconverted to indomethacin, but produces significantly less gastric damage than indomethacin. This study was performed to investigate several possible mechanisms that could account for the gastrointestinal tolerability of acemetacin.	es
dc.language	es	en_US
dc.subject	Farmacología de la Reproducción y Analgesia inducida por neuroesteroides y AINES	es
dc.title	Lack of effects of acemetacin on signalling pathways for leukocyte adherence may explain its gastrointestinal safety	es
dc.type	Article	en_US